Liraglutide, marketed as Victoza, outperformed the established anti-obesity drug orlistat, commercialised as Alli or Xenical, among 564 European volunteers, it suggests.
Friday, October 23, 2009
Fat Wars - watch out Alli!
A hormone drug licensed for diabetes also helps obese people lose weight when used in combination with a low-fat diet and physical exercise, according to a trial published online on Friday by The Lancet.
Liraglutide, marketed as Victoza, outperformed the established anti-obesity drug orlistat, commercialised as Alli or Xenical, among 564 European volunteers, it suggests.
Liraglutide, marketed as Victoza, outperformed the established anti-obesity drug orlistat, commercialised as Alli or Xenical, among 564 European volunteers, it suggests.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment